Literature DB >> 34984685

The impact of the COVID-19 outbreak on activation of the massive transfusion protocol in the emergency department.

Cheng-Xin Yang1, Pei-Chin Lin2, Chih-Chun Chang2,3, Huang-Wen Tsai4,5, Jen-Tang Sun1,6.   

Abstract

BACKGROUND AND OBJECTIVES: An outbreak of coronavirus disease 2019 (COVID-19) occurred in mid-May of 2021 in Taiwan. After 2 months of hard work, transmissions were successfully prevented and the number of newly confirmed COVID-19 cases fell remarkably. We evaluated the impact of this outbreak on the massive transfusion protocol (MTP) in the emergency department (ED) of a trauma centre.
MATERIALS AND METHODS: We retrospectively compared the activation and efficacy of MTP before, during and after the outbreak by analysing the clinical data relevant to MTP activations.
RESULTS: There was no remarkable change in the average number of MTP triggers per month during the outbreak. The interval from an MTP trigger to the first unit of blood transfused at bedside was significantly increased during the outbreak compared to that before the outbreak (22.4 min vs. 13.9 min, p < 0.001); while the 24-h survival rate decreased (57.1% vs. 71.1%, p = 0.938). There were no remarkable changes in blood unit return or wastage during the outbreak.
CONCLUSION: The COVID-19 outbreak limitedly affected MTP activation and waste of blood products, but significantly increased the interval from an MTP trigger to the first unit of blood transfused at bedside.
© 2022 International Society of Blood Transfusion.

Entities:  

Keywords:  COVID-19; massive transfusion protocol; patient blood management; trauma

Mesh:

Year:  2022        PMID: 34984685     DOI: 10.1111/vox.13238

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.996


  2 in total

1.  Reply to Jacobs et al.: Massive transfusion protocols during the COVID-19 pandemic.

Authors:  Chih-Chun Chang; Jen-Tang Sun
Journal:  Vox Sang       Date:  2022-03-29       Impact factor: 2.996

2.  Massive transfusion protocols during the COVID-19 pandemic.

Authors:  Jeremy W Jacobs; Brian D Adkins; Garrett S Booth
Journal:  Vox Sang       Date:  2022-03-29       Impact factor: 2.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.